NVWM LLC’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.33K | Hold |
88
| – | – | ﹤0.01% | 340 |
|
|
2025
Q4 | $4.72K | Buy |
88
+26
| +42% | +$1.25K | ﹤0.01% | 362 |
|
|
2025
Q3 | $2.8K | Buy |
62
+5
| +9% | +$234 | ﹤0.01% | 394 |
|
|
2025
Q2 | $2.63K | Sell |
57
-14
| -20% | -$687 | ﹤0.01% | 388 |
|
|
2025
Q1 | $4.35K | Buy |
71
+10
| +16% | +$583 | ﹤0.01% | 326 |
|
|
2024
Q4 | $3.45K | Buy |
61
+29
| +91% | +$1.62K | ﹤0.01% | 340 |
|
|
2024
Q3 | $1.66K | Buy |
32
+10
| +45% | +$469 | ﹤0.01% | 398 |
|
|
2024
Q2 | $914 | Sell |
22
-17
| -44% | -$761 | ﹤0.01% | 454 |
|
|
2024
Q1 | $2.12K | Buy |
+39
| New | +$1.99K | ﹤0.01% | 353 |
|
|
2023
Q4 | – | Sell |
-100
| Closed | -$5.8K | – | 415 |
|
|
2023
Q3 | $5.8K | Sell |
100
-179
| -64% | -$11K | ﹤0.01% | 346 |
|
|
2023
Q2 | $17.8K | Sell |
279
-9,671
| -97% | -$649K | 0.01% | 307 |
|
|
2023
Q1 | $690K | Sell |
9,950
-54
| -0.5% | -$3.81K | 0.23% | 130 |
|
|
2022
Q4 | $721K | Sell |
10,004
-30
| -0.3% | -$2.26K | 0.26% | 118 |
|
|
2022
Q3 | $714K | Sell |
10,034
-3
| -0% | -$218 | 0.28% | 117 |
|
|
2022
Q2 | $772K | Buy |
10,037
+9,937
| +9,937% | +$757K | 0.3% | 109 |
|
|
2022
Q1 | $7K | Sell |
100
-250
| -71% | -$16.8K | ﹤0.01% | 402 |
|
|
2021
Q4 | $18K | Sell |
350
-269
| -43% | -$15.8K | 0.01% | 334 |
|
|
2021
Q3 | $37K | Hold |
619
| – | – | 0.01% | 274 |
|
|
2021
Q2 | $41K | Sell |
619
-84
| -12% | -$5.48K | 0.01% | 266 |
|
|
2021
Q1 | $45K | Sell |
703
-854
| -55% | -$53.1K | 0.02% | 246 |
|
|
2020
Q4 | $96K | Sell |
1,557
-599
| -28% | -$36.8K | 0.04% | 179 |
|
|
2020
Q3 | $130K | Buy |
2,156
+599
| +38% | +$36.1K | 0.06% | 157 |
|
|
2020
Q2 | $92K | Sell |
1,557
-500
| -24% | -$29.9K | 0.05% | 158 |
|
|
2020
Q1 | $115K | Buy |
2,057
+2,014
| +4,684% | +$123K | 0.08% | 144 |
|
|
2019
Q4 | $3K | Sell |
43
-580
| -93% | -$33.2K | ﹤0.01% | 281 |
|
|
2019
Q3 | $32K | Hold |
623
| – | – | 0.02% | 216 |
|
|
2019
Q2 | $28K | Hold |
623
| – | – | 0.02% | 228 |
|
|
2019
Q1 | $30K | Sell |
623
-7
| -1% | -$349 | 0.02% | 202 |
|
|
2018
Q4 | $33K | Sell |
630
-8,936
| -93% | -$480K | 0.02% | 194 |
|
|
2018
Q3 | $594K | Buy |
9,566
+9,045
| +1,736% | +$537K | 0.38% | 83 |
|
|
2018
Q2 | $29K | Sell |
521
-201
| -28% | -$10.9K | 0.02% | 202 |
|
|
2018
Q1 | $44K | Buy |
722
+500
| +225% | +$32.2K | 0.03% | 186 |
|
|
2017
Q4 | $14K | Buy |
+222
| New | +$13.9K | 0.01% | 230 |
|
Other funds holding BMY
VCM
VPM
NVWM LLC's BMY Position: Q1 2026 in Review
NVWM LLC held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 88 shares worth $5.33K. The position accounts for ﹤0.01% of the portfolio, ranked #340.
NVWM LLC first reported a position in BMY in Q4 2017 and has held it in 33 quarters since. The position peaked at $772K in Q2 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- NVWM LLC held 88 shares of Bristol-Myers Squibb worth $5.33K as of Q1 2026.
- NVWM LLC left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up ﹤0.01% of NVWM LLC's portfolio in Q1 2026, its #340 holding.
- NVWM LLC first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 33 quarters since.
- NVWM LLC's Bristol-Myers Squibb position peaked at $772K in Q2 2022.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on NVWM LLC's 13F filing for Q1 2026, filed 27 Apr 2026.